The largest database of trusted experimental protocols

Anti vegf antibody

Manufactured by Santa Cruz Biotechnology
Sourced in United States, United Kingdom

The Anti-VEGF antibody is a laboratory tool used to detect and study the Vascular Endothelial Growth Factor (VEGF) protein. VEGF is a signaling protein involved in the formation of new blood vessels. The Anti-VEGF antibody can be used in various research applications to identify and quantify VEGF levels in biological samples.

Automatically generated - may contain errors

16 protocols using anti vegf antibody

1

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retrieved tumor tissues were fixed in 10% formalin and embedded in paraffin. Serial sections of the embedded specimens were stained with hematoxylin and eosin (H&E). For immunohistochemical staining, slides were deparaffinized and then rehydrated in a graduated fashion. The deparaffinized slides were subjected to antigen retrieval and probed with anti-PCNA, anti-HIF-1α, or anti-VEGF antibody (Santa Cruz Biotechnology) or isotype IgG control, followed by incubation with biotin secondary antibodies and streptavidin-horseradish peroxidase. The presence of the expected protein was visualized by DAB staining and examined under a microscope. Stains without the primary antibody or with control IgG were used as negative controls [54 (link)].
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of VEGF, Slit2, and Robo1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human fibrovascular membrane tissues were snap-frozen and 6 μm sections were cut. Thawed tissue sections were air dried, placed in 4% PFA for 20 min for fixing, washed with PBS, and blocked with 10% normal goat serum for 1 h at 37°C. Next, 1:100 anti- VEGF antibody (Santa Cruz, Santa Cruz, CA) in combination with either 1:200 anti-Slit2 polyclonal antibody (Millipore, Temecula, CA) or 1:100 anti-Robo1 polyclonal antibody (Abcam, Cambridge, UK) together at the same time were applied to the tissue sections at 4°C overnight and incubated for 1 h at 37°C with 1:100 fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit and tetramethyl rhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse secondary antibodies (Santa Cruz, CA, USA) as appropriate. Following incubation, the slides were washed, and cell nuclei were stained with 4’, 6’-diamino-2- phenylindole (DAPI). Images were acquired using a fluorescence microscope equipped with a digital camera. For each of the immunostaining procedures, negative controls included the omission of the primary antibody and the use of an irrelevant polyclonal or isotype-matched monoclonal primary antibody. In all cases, negative controls showed only faint, insignificant staining.
+ Open protocol
+ Expand
3

Quantitative VEGF Expression Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
VEGF expression levels were evaluated by an eight-year work experience pathologist using typical tumor samples collected from the patients. Immunostaining was performed using an anti-VEGF antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:100 in accordance with the manufacturer’s instructions. Briefly, formalin-fixed paraffin-embedded tissue sections were cut into 5-μm sections, which were then dried, dewaxed in xylene, rinsed in graded ethanol, and rehydrated in double-distilled water. Two pathologists who were blind to the clinical data scored the degree of staining. VEGF expression level was scored according to clinical practice: (−) represented no or rare expression (< 5% positive cells); (+) represented mild expression (6–25% positive cells); (++) represented moderate expression (26–50% positive cells); and (+++) represented strong expression (> 50% positive cells). Low VEGF expression was defined as VEGF (− and +), and high VEGF expression was defined as VEGF (++ and +++) [29 (link)].
+ Open protocol
+ Expand
4

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein expression levels of MDM2, p53, VEGF, caspase-3, cleaved caspase-3, and poly(ADP-ribose) polymerase (PARP) were analyzed by western blot. The following antibodies were used: anti-MDM2 antibody (1:1000; Sigma), anti-p53 antibody (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-VEGF antibody (1:200; Santa Cruz Biotechnology), anti-caspase-3 antibody (1:1000; Santa Cruz Biotechnology), anti-cleaved caspase-3 p11 antibody (1:1000; Santa Cruz Biotechnology), and anti-PARP antibody (1:1000; Cell Signaling, Danvers, MA, USA).
+ Open protocol
+ Expand
5

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty μg of protein were loaded onto 10 % SDS gel coupled with loading buffer. Then the protein was transferred to nitrocellulose (NC) membrane and the nonspecific binding sites were blocked using 5 % non-fat dry milk. Then the NC membrane was incubated with diluted anti-ZNF217 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (1:200), anti-total CREB antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (1:200), anti-aromatase antibody (Abcam, Cambridge, UK) (1:1000), anti-VEGF antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (1:200) at 4 °C for overnight. After washing with TBST, membrane was incubated with diluted peroxidase-conjugated secondary antibodies for 1 h at room temperature. At last, the protein signals were detected using ECL western blotting substrate.
+ Open protocol
+ Expand
6

Molecular Pathway Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gremlin, RAD001, rapamycin and perifosine were purchased from Sigma Chemicals (Shanghai, China). AZD8055 and OSI-027 were purchased from Selleck (Nanjing, China). All phosphorylation antibodies and their non-phosphorylated controls were obtained from Cell Signaling Tech (Danvers, MA). Anti-VEGF antibody and all other antibodies were purchased from Santa Cruz Biotech (Santa Cruz, CA).
+ Open protocol
+ Expand
7

Western Blot Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot (WB) was performed as described previously (20 (link)). The anti-PlGF, anti–hypoxia-inducible factor (HIF)-1α, anti-VEGFR1, anti-VEGFR2, anti–intercellular adhesion molecule (ICAM)-1, anti–vascular cell adhesion molecule (VCAM)-1, anti-ZO-1, and anti-VE-cadherin antibodies are described in more detail elsewhere (21 (link),22 (link)). Dilutions of 1:200 and 1:1,000 were used for anti-VEGF antibody (Santa Cruz, Dallas, TX) and anti-VEGFR3 antibody (eBioscience, San Diego, CA), respectively. The anti-Akt and anti-phospho (p)-Akt antibodies were bought from Cell Signaling (Indiana, IN) and used as 1:1,000 dilutions.
The optical density (OD) of protein bands in WB images was determined by ImageJ (National Institutes of Health). After normalization by dividing the OD of protein of interest with the housekeeping gene β-actin of the same sample, the percentage of the normalized OD was calculated for each protein of interest based on this equation: percentage of OD (4) = 100*OD (4) / [OD (1) + OD (2) + OD (3) + OD (4)] (each represents one retinal protein sample in the same WB membrane). The average percentage of normalized OD was designated as the relative protein expression (n = 6).
+ Open protocol
+ Expand
8

Quantifying VEGF and Caspase-3 in Bone Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein levels of VEGF and caspase-3 p17 in bone tissue were determined by western blot analysis. Bone tissue samples were lysed in RIPA buffer containing protease inhibitor cocktail (PIC, Sigma, USA). Lysate samples (50 µg protein) were electrophoresed on 15% SDS-PAGE gel and then transferred onto nitrocellulose membranes. The membranes were blocked and then incubated with anti-VEGF antibody (1 : 500, Santa Cruz Biotechnology, USA) and anti-caspase-3 antibody (1 : 1000, Santa Cruz Biotechnology, USA) overnight at +4°C followed by incubation with secondary antibodies: anti-rabbit IgG (H + L)-HRP conjugate (1 : 4000; Bio-Rad Laboratories, Inc., USA) and anti-mouse IgG (Fab specific)-Peroxidase (1 : 2500; Sigma, USA) for 1 h at room temperature. Thereafter, the membranes were developed with chemiluminescent agents: p-coumaric acid (Sigma, USA) and luminol (AppliChem GmbH, Germany). VEGF and caspase-3 tissue levels were normalized to β-actin (1 : 10000; Sigma, USA). The immunoreactive bands were quantified with Gel-Pro Analyzer v3.1 software.
+ Open protocol
+ Expand
9

Western Blot Analysis of Apoptotic and Angiogenic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small intestine (100 mg) was lysed and homogenized in 1 ml lysis buffer (10 mM TBS, 1 mM EDTA, 1 mM EGTA, 2 mM sodium orthovanadate, 0.2 mM PMSF, 2 μg⁄ml leupeptin, 2 μg ⁄ml aprotinin, and 1% Triton X-100) for 30 min on ice and cleared by centrifugation at 12,000 g for 15 min at 4°C. Protein (80 μg) was fractionated on a 4 to 12% Bis-Tris gel and transferred to a 0.2-μm nitrocellulose membrane. Nitrocellulose blots were blocked by incubation in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1%Tween 20) containing 5% milk for 1 h at room temperature. Western blotting was performed using the following primary antibodies at 1:1,000 dilutions: anti-Bcl-xl antibody, anti-Bcl-2 polyclonal antibody (N-19), anti-Bax antibody, anti-VEGF antibody (Santa Cruz Biotechnology), and anti-pAkt antibody (Cell Signaling). After overnight incubation with the primary antibodies at 4˚C, the membranes were washed with TBST. Immunoreactive bands were detected using HRP-linked secondary antibody (Southern Biotech, Birmingham, AL) and the Enhanced Chemiluminescence (ECL) Western blot detection kit (Amersham, Piscataway, NJ). The immunoblots were exposed to X-ray film and analyzed with the NIH Image J analysis system. Mouse anti-β-actin monoclonal antibody (1:10,000; Sigma) was used as a loading control.
+ Open protocol
+ Expand
10

Progesterone Assay for Antioxidant Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Progesterone (H33020828) was purchased from Zhejiang Xian Ju Pharmaceutical Co, Ltd (Zhejiang, China). SOD and MDA test kits were purchased from Nanjing Jiancheng Biology Institution (Nanjing City, Jiangsu Province, China). Anti-VEGF antibody was purchased from Santa Cruz Biotechnology (Dallas, TX, USA), and Cedar Bridge Company (Beijing, China) was the source of goat anti-rat immunoglobulin G-R (IgG-R).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!